ICU sedation, delirium & recovery
Comparison of NeuroSENSE® and SedLine® for measuring depth of sedation in the intensive care unit: an observational study: The PSIWAV study
Authors' conclusion
There is no difference in performance in predicting the DoS in critically ill patients sedated with propofol and remifentanil or morphine in a mixed ICU population between the SedLine® and the NeuroSENSE® DoS monitor.
Study context
- Population
- Critically ill adults sedated with propofol with or without remifentanil or morphine, mixed medical and surgical intensive care unit (ICU) of a tertiary academic hospital
- Participants
- 30 adults
- Exposure
- NeuroSENSE® vs SedLine® depth of sedation (DoS) monitor
- Outcome
- Agreement between DoS and Richmond Agitation Sedation Scale (RASS), by prediction probability (PK; 0 discordance to 1 perfect agreement)
Methodological detailssingle-centre, comparative
- Single-centre
- Comparative
Main finding
As reported in the abstract
PK for RASS
SedLine®
0.826
± 0.034
NeuroSENSE® right hemisphere
0.809
± 0.032
NeuroSENSE® left hemisphere
0.797
± 0.033
Observational data: associations, not effects.
Original publication
Comparison of NeuroSENSE® and SedLine® for measuring depth of sedation in the intensive care unit: an observational study: The PSIWAV study. Eur J Anaesthesiol Intensive Care. Published 19 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →